Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 6901 to 6915 of 8904 results

  1. Atezolizumab for adjuvant treatment of high-risk locally advanced squamous cell head and neck cancer [ID4052]

    Discontinued Reference number: GID-TA10933

    Technology appraisal guidance
    Discontinued

  2. Pralsetinib for thyroid cancer [ID4018]

    Discontinued Reference number: GID-TA10910

    Technology appraisal guidance
    Discontinued

  3. Olaparib with cediranib for treating platinum-resistant recurrent ovarian cancer after 1 or 2 therapies [ID4065]

    Discontinued Reference number: GID-TA11033

    Technology appraisal guidance
    Discontinued

  4. Superior rectal artery embolisation for haemorrhoids

    Discontinued Reference number: GID-IPG10417

    Interventional procedures guidance
    Discontinued

  5. Empagliflozin for type 1 Diabetes Mellitus, adjunct to insulin ID1275

    Discontinued Reference number: GID-TA10375

    Technology appraisal guidance
    Discontinued

  6. Improving outcomes in haemato-oncology cancer (CSG3)

    This guidance has been updated and replaced by NICE guideline NG47.

    Withdrawn guideline

  7. Improving outcomes in colorectal cancer (CSG5)

    This guidance has been updated and replaced by NICE guideline NG151.

    Withdrawn guideline

  8. Extracorporeal albumin dialysis for acute-on-chronic liver failure (IPG45)

    This guidance has been updated and replaced by NICE HealthTech guidance 202.

    Withdrawn guidance

  9. Microwave ablation for treating primary lung cancer and metastases in the lung (IPG469)

    This guidance has been updated and replaced by NICE interventional procedures guidance 716.

    Withdrawn guidance

  10. Sutureless aortic valve replacement for aortic stenosis (IPG456)

    Interventional procedures, IPG456 - Issued: July 2013 --> This guidance has been updated and replaced by NICE interventional procedures guidance 624.

    Withdrawn guidance

  11. Percutaneous electrical nerve stimulation for refractory neuropathic pain (IPG450)

    Interventional procedures, IPG450 - Issued: March 2013 --> We have moved interventional procedures guidance 450 to become HealthTech guidance 308. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  12. Photodynamic endometrial ablation (IPG47)

    We have moved interventional procedures guidance 47 to become HealthTech guidance 23. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  13. Insertion of customised exposed titanium implants, without soft tissue cover, for complex orofacial reconstruction (IPG457)

    Interventional procedures, IPG457 - Issued: July 2013 --> We have moved interventional procedures guidance 457 to become HealthTech guidance 313. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  14. Endoscopic bipolar radiofrequency ablation for treating biliary obstruction caused by cholangiocarcinoma or pancreatic adenocarcinoma (IPG464)

    This guidance has been updated and replaced by NICE interventional procedures guidance 614.

    Withdrawn guidance

  15. Peripheral nerve-field stimulation for chronic low back pain (IPG451)

    Interventional procedures, IPG451 - Issued: March 2013 --> We have moved interventional procedures guidance 451 to become HealthTech guidance 309. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance